Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
暂无分享,去创建一个
M. Lux | M. Beckmann | P. Fasching | T. Fehm | A. Schneeweiss | D. Wallwiener | H. Tesch | T. Ganslandt | V. Müller | W. Janni | N. Nabieva | F. Taran | M. Wallwiener | S. Brucker | A. Hartkopf | M. Rübner | C. Rauh | J. Ettl | P. Hadji | D. Lüftner | B. Volz | F. Heindl | P. Gass | H. Langemann | H. Kolberg | F. Overkamp | T. Brodkorb | E. Belleville | Carla E. Schulmeyer | S. Blum | C. Faschingbauer | Cornelia Faschingbauer | Tobias Brodkorb
[1] A. Lucia,et al. Validity of the Physical Activity Questionnaires IPAQ-SF and GPAQ for Cancer Survivors: Insights from a Spanish Cohort , 2016, International Journal of Sports Medicine.
[2] L. V. van't Veer,et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.
[3] M. Lux,et al. Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients , 2016, Breast Cancer Research and Treatment.
[4] R. La Touche,et al. The level of physical activity affects the health of older adults despite being active , 2016, Journal of exercise rehabilitation.
[5] E. Basch,et al. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments , 2016, Nature Reviews Clinical Oncology.
[6] P. Fasching,et al. Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills , 2016, Geburtshilfe und Frauenheilkunde.
[7] N. Probst-Hensch,et al. Associations between domains of physical activity, sitting time, and different measures of overweight and obesity , 2016, Preventive medicine reports.
[8] Amy P Abernethy,et al. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). , 2015, JAMA oncology.
[9] Virginia G Kaklamani,et al. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. , 2015, The New England journal of medicine.
[10] T. Reimer,et al. Patient-Reported Outcomes in Implant-Based Breast Reconstruction Alone or in Combination with a Titanium-Coated Polypropylene Mesh – A Detailed Analysis of the BREAST-Q and Overview of the Literature , 2015, Geburtshilfe und Frauenheilkunde.
[11] A. Schneeweiss,et al. Chemotherapie desmetastasiertenMammakarzinoms – ein Anachronismus in der Ära der personalisierten zielgerichteten onkologischenTherapie ? Chemotherapy for Metastatic Breast Cancer – An Anachronism in the Era of Personalised and Targeted Oncological Therapy ? , 2015 .
[12] R. Plinta,et al. The role of physical activity in preventing obesity in midlife women , 2015, Przeglad menopauzalny = Menopause review.
[13] H Tesch,et al. Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network. , 2015, Geburtshilfe und Frauenheilkunde.
[14] E. Basch. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. , 2014, Annual review of medicine.
[15] Dan Li,et al. A meta-analysis of the prevalence of depressive symptoms in Chinese older adults. , 2014, Archives of gerontology and geriatrics.
[16] Deborah Schrag,et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] M. Lux,et al. Breast Cancer 2013 – Interpretation of New and Known Data , 2013 .
[18] I. Kollak,et al. Yoga for Patients with Early Breast Cancer and its Impact on Quality of Life - a Randomized Controlled Trial. , 2013, Geburtshilfe und Frauenheilkunde.
[19] C. Garbe,et al. Akzeptanz und Reliabilität eines elektronischen psychoonkologischen Screenings bei Patientinnen mit Brustkrebs: eine randomisiert-kontrollierte Studie , 2013, Psychotherapie - Psychosomatik - Medizinische Psychologie.
[20] D. Wallwiener,et al. [Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study]. , 2013, Psychotherapie, Psychosomatik, medizinische Psychologie.
[21] David Cella,et al. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment , 2013, Supportive Care in Cancer.
[22] K. Possinger,et al. Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer , 2012, Breast Cancer Research and Treatment.
[23] Lennart Bodin,et al. The use of weekly text messaging over 6 months was a feasible method for monitoring the clinical course of low back pain in patients seeking chiropractic care. , 2012, Journal of clinical epidemiology.
[24] M. Piccart,et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. , 2012, The New England journal of medicine.
[25] Jordi Rodon,et al. Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] W. Mechelen,et al. Self-Administered Physical Activity Questionnaires for the Elderly , 2010, Sports medicine.
[27] Maria Hagströmer,et al. The International Physical Activity Questionnaire modified for the elderly: aspects of validity and feasibility , 2010, Public Health Nutrition.
[28] Alexia Iasonos,et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. , 2009, Journal of the National Cancer Institute.
[29] E. Basch. Patient-reported outcomes in drug safety evaluation. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] A. Abernethy,et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. , 2009, Journal of pain and symptom management.
[31] David Cella,et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[32] David Artz,et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] U. S. Department of Health and Human Services FDA Cen Research,et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.
[34] N. Leidy,et al. Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: a review of guidance documents and performed authorizations of medicinal products 1995 to 2003. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[35] R. Willke,et al. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. , 2004, Controlled clinical trials.
[36] M. Mori,et al. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.